Follows children using medical cannabis for cancer, epilepsy or neurodevelopmental disorders
Observes 500 children aged 3 to 17 who have medical cannabis authorizations.
Key facts
- Who runs it
- University of Manitoba
- Where
- Winnipeg, CanadaSee the site
- Trial code
- Registry title
- Real World Evidence on the Use of Medical Cannabis in Pediatrics
- Status
- Recruiting
- People taking part
- 500 people, planned
- Started
- 20 Nov 2023
- Expected to end
- 31 Dec 2027
- Type of study
- Observational, 3 groups
- Treatments tested
- Medical Cannabis
- Record updated
- 30 November 2023
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for children aged 3 to 17 who have a medical cannabis authorization from a health care provider. They are followed for two years.
- Age
- 3 to 17 years
- Sex
- All sexes can join.
- Disease stage
- Medical cannabis must be authorized for pain, sleep, mood, behaviour, seizures, or symptoms of cancer or its treatment.
- Earlier treatment
- A medical document from a prescribing health care practitioner for the use of medical cannabis is needed.
Main reasons for not taking part
- Using cannabis for medical reasons without a medical cannabis authorization from a health care provider
- Using cannabis only for recreation
The registry criteria, word for word
Show all 6 criteriaShow less
Who can take part
- 3 to 17 years
- have a medical document provided by a prescribing health care practitioner (i.e. physician, nurse practitioner, etc.) for the use of medical cannabis
- medical cannabis is authorized for pain, sleep, mood, behaviour, seizures, cancer or cancer-treatment related symptom management
- ability to respond to electronic questionnaires in English
Who cannot take part
- individuals using cannabis for medical purposes without a medical cannabis authorization from a health care provider
- those only using cannabis recreationally
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 3 and 17 years old?
Where in Canada
- U ManitobaWinnipeg, CanadaContact: Lauren Kelly, PhDTaking people
About the trial
What the trial wants to find out
CAN-RWE is an observational study that is following 500 children who have authorizations for medical cannabis for two years from across Canada.
The 3 groups in the trial
- Epilepsy Cohort
For children with epilepsy, the following tools will be added for data collection at each time point: * Side effects: Pediatric Epilepsy Side Effects Questionnaire \[PESQ\] * Seizure frequency/severity: Seizure Diary Data Questionnaire
Treatment: Medical Cannabis
- Cancer Cohort
For children with cancer, the following tools will be added for data collection at each time point: * Cancer symptom burden: Symptom Screening in Pediatrics Tool \[SSPedi\] * Cachexia: Pediatric Functional Assessment of Anorexia/ Cachexia Treatment \[peds-FAACT\]
Treatment: Medical Cannabis
- General Pediatrics Cohort
There are no specific outcome scales added for this cohort.
Treatment: Medical Cannabis
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Real World Evidence on the Use of Medical Cannabis in Pediatrics: A Prospective Observational Study
- Plain-language title
- Follows children using medical cannabis for cancer, epilepsy or neurodevelopmental disordersGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Fit questions
- Built from NCT05863910, who can take part
- Record updated
- 30 November 2023